CD47 and cancer: The interaction between CD47 and SIRPα on macrophages inhibits phagocytosis, serving as a “don’t eat me” signal, which may counteract pro-inflammatory responses mediated by cancer therapeutic antibodies, reducing therapeutic efficacy.